Esophageal Cancer Education Foundation

Home
United States
Manalapan, NJ
Esophageal Cancer Education Foundation

Shinning the Light on Esophageal Cancer. We are a Non Profit 501 C 3 organization Mr. With Mr. Frazzitta, ECEF has established a website, www.fightec.org.

The Esophageal Cancer Education Foundation (ECEF) was established in 2003 to educate the public and medical community about the dangers of esophageal cancer and to assist newly diagnosed patients with their journey through treatment. Founded by Bart Frazzitta, an EC survivor whose own experience and work as a patient-to-patient volunteer with newly diagnosed esophageal cancer patients at Memorial Sloan-Kettering Cancer Center in New York City, made him realize how little information there was on this subject. ECEF has rapidly moved forward with a far-reaching vision, to address the lack of awareness and education surrounding Esophageal Cancer. Frazzitta co-authored a book, 100 Questions & Answers about Esophageal Cancer and produced an educational CD-Rom for patients along with Memorial Sloan-Kettering Cancer Center. ECEF has 3 Missions:

1) To educate the public and medical community about esophageal cancer.

2) To walk the journey with patients who have this disease.

3) To support research projects that focus on an early warning test for this disease.

11/04/2026

https://www.oncologynewscentral.com/oncology/private-sector-helps-improve-clinical-trial-enrollment-in-community-oncology-practices

Explore how private sector initiatives are supporting community oncology practices in offering clinical trials, addressing barriers to access and improving patient outcomes.

11/04/2026

https://www.2minutemedicine.com/zanidatamab-hrii-combinations-improved-survival-in-first-line-her2-positive-advanced-gastroesophageal-adenocarcinoma/

In company-reported phase 3 results, zanidatamab-hrii plus chemotherapy improved overall survival versus trastuzumab plus chemotherapy, with median overall…

10/30/2026

https://people.com/kim-kardashian-says-esophagitis-diagnosis-is-heavy-on-my-mind-12199019

Kim Kardashian says she needs surgery for throat irregularities after an esophagitis diagnosis, citing concerns tied to her family history.

10/29/2026

https://www.gastroendonews.com/Esophageal-Disorders/Article/10-26/Alcohol-Use-and-Barrett-s-Esophagus-Progression/82018

Alcohol consumption was associated with a more than sixfold higher risk for progression to high-grade dysplasia and esophageal adenocarcinoma among patients with nondysplastic Barrett’s esophagus, according to a large retrospective study presented at ACG 2026.

10/25/2026

https://news.unchealthcare.org/2026/10/unc-researchers-investigate-why-some-stomach-and-esophageal-cancers-resist-immunotherapy/

A $3 million grant from the Mark Foundation will help a team of UNC School of Medicine experts identify ways to solve immunotherapy resistance, a growing problem in patients with stomach and esophageal cancer.

10/19/2026

https://www.northside.com/about/news-center/articles/2026/09/25/advanced-endoscopy-program-grows-expands-treatment-options

Northside Hospital’s advanced endoscopy program is expanding access to minimally invasive treatments for esophageal cancer, achalasia, gastroparesis and other complex digestive disorders, helping patients avoid major surgery and stay close to home.

10/19/2026

https://bioengineer.org/esophageal-cancer-at-a-crossroads-landmark-review-maps-molecular-drivers-and-next-generation-therapies/

A comprehensive Chinese Medical Journal review led by Professor Feng Wang synthesizes five years of advances in esophageal cancer, highlighting immunotherapy breakthroughs, slower targeted therapy

10/19/2026

https://www.sciencealert.com/drinking-very-hot-tea-or-coffee-could-triple-your-risk-of-this-cancer-huge-study-finds

Plenty of people like to start their day with a cup of tea or coffee, but the temperature of your preferred beverage could matter a lot more than you realize.

10/16/2026

https://oncodaily.com/gastrointestinal-oncology/esmo-2026

10 Gastroesophageal Cancer Trials to Watch at ESMO 2026 / cancer, cancer care, Cancer research, cancer treatment, chemotherapy, clinical trials, ESMO, ESMO

10/06/2026

https://news.cancerconnect.com/fda-approves-new-first-line-treatment-options-for-her2-positive-advancedgastric-and-gej-cancer/

The FDA has approved new first-line zanidatamab-based treatment options for certain people with HER2-positive advanced stomach, gastroesophageal junction, and esophageal cancers. In a major clinical trial, the combination of zanidatamab, tislelizumab, and chemotherapy extended survival and delayed c...

Address

Manalapan, NJ

Telephone

732-385-7461

Website

https://fightec.org/

Alerts

Be the first to know and let us send you an email when Esophageal Cancer Education Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.